The Amgen Bioprocessing Center Advisory Board (ABCAB) consists of scientists, engineers, academics, and corporate executives who provide support and advice to KGI’s Amgen Bioprocessing Center.

Mr. Daniel Abramzon
Senior Finance Manager, Genentech, Inc.

Dr. Ashraf Amanullah
VP, Process Development and Manufacturing, a Tyr Pharma

Mr. Vincent Anicetti
SVP, Quality and Compliance, Coherus Biosciences (ABCAB Chair 2016- ) 

Dr. John Aunins
Founder, Janis Biologics LLC 

Francis Bach
Director, Sartorius-Stedim Biotech

Dr. Robert Baffi
EVP, operation, BioMarin Pharmacteutical, Inc. (ABCAB Chair – 2014-2015) 

Joaquim Cabral
Professor & Director, Institute of B&B, University of Lisbon Instituto Superior Técnico

Dr. Jon Coffman
Director, Bioprocess Development, Boehringer Ingelheim 

Tom Cortopassi
Director, Sartorius Stedim

Dr. Larry A. Couture
SVP & Founding Director, City of Hope 

Dr. Dennis M. Fenton
Principal, Fenton & Associates LLC 

Tom Fletcher
Scientific Director, Irvine Scientific 

Dr. Nuno Fontes
Executive Director, Site Head of Process Science, Boehringer-Ingelheim

Mr. Robert Garrahy
VP, Bioprocess Technogies, Broadley-James Corporation

Ms. Amita Goel
Founder and CEO, Celltheon Corporation

Dr. Sam Guhan
VP, Process Development, Amgen, Inc.

Dr. Robert Kiss
Director, Genentech, Inc.

Dr. Brian Lee
President, CEO and Founder, PBS Biotech 

Rick Lit
Former VP, Regulatory Affairs and Safety CMC/Biosimilars/Devices

Dr. Gargi Maheshwari
Executive Director, Merck & Co 

Bill Rich
VP, External Supply, Amgen 

Mr. Vinit Saxena
President and CEO, Separagen Corporation

Chris Schilling
President and CSO, Genomatica Genomatica

Dr. Abhinav Shukla
VP, Process Development and Manufacturing, KBI Biopharma, Inc.

Dr. Tom Smart
Chairman, Buffer Exchange, TheraBiologics Full Spectrum Genetics, Inc.

Weichang Zhou
VP,  China WuXi AppTec Co., Ltd.